title: Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.
abstract: The chimera of modern biotechnology is defined broadly as a single organism composed of a mixture of materials from two or more organisms possessing distinct genetic backgrounds. Unlike the United States, which does not regulate chimeras directly, Canada has responded to the unregulated pursuit of chimera technology by banning certain chimeras as part of comprehensive legislation designed to regulate human reproductive technologies. In 2004, the Canadian Parliament passed the Assisted Human Reproduction Act despite criticism urging greater legislative justification for the Act's provisions and modification to it statutory definitions. Because current regulatory mechanisms in the United States, including patent law and administrative oversight, fail to regulate chimera technology, the United States should enact new legislation, using Canada's legislation as a model, to prohibit embryonic chimeras and to regulate other human-nonhuman combinations. Unregulated biotechnology threatens to disrupt legal and social institutions; therefore, the United States must make a balanced effort now to protect the public interest.
authors.forename: Nicole E
authors.initials: NE
authors.lastname: Kopinksi
mesh_terms: D026683:Advisory Committees; D017087:Animal Rights; D000818:Animals; D001709:Biotechnology / Q000331:legislation & jurisprudence; D002170:Canada; D002678:Chimera / Q000145:classification; D033041:Embryo Research / Q000941:ethics / Q000331:legislation & jurisprudence; D028663:Ethical Theory; D033161:Government Regulation; D006801:Humans; D007878:Legislation as Topic; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D027724:Reproductive Techniques, Assisted / Q000331:legislation & jurisprudence; D013045:Species Specificity; D014481:United States; D014486:United States Food and Drug Administration